Clinical Trial Update: Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy of a sodium-glucose transporter 2 inhibitor in adults with congenital heart disease and heart failure, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Heart Failure

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Anita Saraf | Conditions: Adult Congenital Heart Disease, Heart Failure | Phase 4 | Status: RECRUITING